DNTH
Price
$25.49
Change
-$0.86 (-3.26%)
Updated
Nov 14 closing price
MGTX
Price
$6.64
Change
-$0.40 (-5.68%)
Updated
Nov 14 closing price
117 days until earnings call
Ad is loading...

DNTH vs MGTX

Header iconDNTH vs MGTX Comparison
Open Charts DNTH vs MGTXBanner chart's image
Dianthus Therapeutics
Price$25.49
Change-$0.86 (-3.26%)
Volume$1.85M
CapitalizationN/A
MeiraGTx Holdings
Price$6.64
Change-$0.40 (-5.68%)
Volume$294.7K
CapitalizationN/A
DNTH vs MGTX Comparison Chart
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
DNTH vs. MGTX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a StrongSell and MGTX is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (DNTH: $25.49 vs. MGTX: $6.64)
Brand notoriety: DNTH and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 717% vs. MGTX: 94%
Market capitalization -- DNTH: $754.43M vs. MGTX: $512.5M
DNTH [@Biotechnology] is valued at $754.43M. MGTX’s [@Biotechnology] market capitalization is $512.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 5 TA indicator(s) are bullish while MGTX’s TA Score has 4 bullish TA indicator(s).

  • DNTH’s TA Score: 5 bullish, 4 bearish.
  • MGTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а -14.75% price change this week, while MGTX (@Biotechnology) price change was -1.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 09, 2023.

MGTX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($754M) has a higher market cap than MGTX($513M). DNTH YTD gains are higher at: 145.096 vs. MGTX (-5.413).
DNTHMGTXDNTH / MGTX
Capitalization754M513M147%
EBITDAN/AN/A-
Gain YTD145.096-5.413-2,680%
P/E Ratio3.53N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
DNTH vs MGTX: Fundamental Ratings
DNTH
MGTX
OUTLOOK RATING
1..100
5525
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
34100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
4336
P/E GROWTH RATING
1..100
70100
SEASONALITY SCORE
1..100
n/a48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DNTH's Valuation (57) in the null industry is in the same range as MGTX (61) in the Biotechnology industry. This means that DNTH’s stock grew similarly to MGTX’s over the last 12 months.

DNTH's Profit vs Risk Rating (34) in the null industry is significantly better than the same rating for MGTX (100) in the Biotechnology industry. This means that DNTH’s stock grew significantly faster than MGTX’s over the last 12 months.

DNTH's SMR Rating (98) in the null industry is in the same range as MGTX (98) in the Biotechnology industry. This means that DNTH’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's Price Growth Rating (36) in the Biotechnology industry is in the same range as DNTH (43) in the null industry. This means that MGTX’s stock grew similarly to DNTH’s over the last 12 months.

DNTH's P/E Growth Rating (70) in the null industry is in the same range as MGTX (100) in the Biotechnology industry. This means that DNTH’s stock grew similarly to MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHMGTX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
0%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Ad is loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with ANNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-3.26%
ANNX - DNTH
40%
Loosely correlated
-3.36%
IMNM - DNTH
36%
Loosely correlated
-3.88%
MGTX - DNTH
36%
Loosely correlated
-5.68%
ATXS - DNTH
33%
Loosely correlated
-4.90%
TNYA - DNTH
30%
Poorly correlated
-3.35%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
-5.68%
NTLA - MGTX
52%
Loosely correlated
-6.15%
BEAM - MGTX
51%
Loosely correlated
-4.33%
EDIT - MGTX
50%
Loosely correlated
-6.42%
ABOS - MGTX
48%
Loosely correlated
+3.16%
QSI - MGTX
47%
Loosely correlated
-1.52%
More